Amgen is the world’s largest independent biotechnology firm. Its therapeutic drugs are used to treat conditions from leukemia and anemia to osteoporosis and arthritis. For the 2014 Innovation Summit in Amgen’s Research and Development group, Schema led a human-centered design process working closely with a team of scientists culminating in a vision prototype of a data-driven user interface for accessing molecule information. The successful reception of the prototype during the Innovation Summit enabled us to continue the project and build a first version of the tool, now used by individuals in both R&D and Process Development at Amgen. Schema continues to work with Amgen to improve Atlas and innovate in the area of molecular data visualization.